These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7113729)

  • 21. An active film-coating approach to enhance chemical stability of a potent drug molecule.
    Desai D; Rao V; Guo H; Li D; Stein D; Hu FY; Kiesnowski C
    Pharm Dev Technol; 2012; 17(2):227-35. PubMed ID: 21073265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants.
    Alebiowu G; Itiola OA
    Acta Pharm; 2003 Dec; 53(4):313-20. PubMed ID: 14769238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The coating of disk surfaces by tablet lubricants, determined by an intrinsic rate of dissolution method.
    Nicklasson M; Brodin A
    Acta Pharm Suec; 1982; 19(2):99-108. PubMed ID: 7102356
    [No Abstract]   [Full Text] [Related]  

  • 26. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIR chemical imaging to guide/support BMS-561389 tablet formulation development.
    Hilden LR; Pommier CJ; Badawy SI; Friedman EM
    Int J Pharm; 2008 Apr; 353(1-2):283-90. PubMed ID: 18182257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cracking of film coatings on film-coated tablets--a theoretical approach with practical implications.
    Rowe RC
    J Pharm Pharmacol; 1981 Jul; 33(7):423-6. PubMed ID: 6115028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terahertz pulsed imaging and near infrared imaging to monitor the coating process of pharmaceutical tablets.
    Maurer L; Leuenberger H
    Int J Pharm; 2009 Mar; 370(1-2):8-16. PubMed ID: 19084585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
    Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
    Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of magnesium stearate on physical properties and biological availability of sulphadiazine tablet formulations.
    Ahmed M; Enever RP
    Pharm Acta Helv; 1978; 53(12):358-64. PubMed ID: 746045
    [No Abstract]   [Full Text] [Related]  

  • 33. Light stability testing of tablets in the Xenotest and the Fadeometer.
    Nyqvist H
    Acta Pharm Suec; 1984; 21(4):245-52. PubMed ID: 6516869
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing impact of manufacturing and package configurations to photosensitive compounds.
    Carvalho TC; Escotet ML; Lin J; Sprockel OL
    Drug Dev Ind Pharm; 2016; 42(6):936-44. PubMed ID: 26460067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the swelling power of tablet disintegrants].
    Modrzejewski F; Wochna L
    Acta Pol Pharm; 1965; 22(4):305-10. PubMed ID: 5865098
    [No Abstract]   [Full Text] [Related]  

  • 36. Tablet Velocity Measurement and Prediction in the Pharmaceutical Film Coating Process.
    Suzuki Y; Yokohama C; Minami H; Terada K
    Chem Pharm Bull (Tokyo); 2016; 64(3):222-7. PubMed ID: 26936049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of iron oxides in the film-coating of tablets].
    Ceschel GC; Gibellini M
    Farmaco Prat; 1980 Nov; 35(11):553-63. PubMed ID: 7461102
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of the particle size of synthetic red iron oxide on the appearance of tablet film coatings.
    Rowe RC
    Pharm Acta Helv; 1985; 60(5-6):157-61. PubMed ID: 4023018
    [No Abstract]   [Full Text] [Related]  

  • 39. Color stability of tablet formulations. I. Measurement of changes in individual tablet reflectance.
    URBANYI T; SWARTZ CJ; LACHMAN L
    J Am Pharm Assoc Am Pharm Assoc; 1960 Mar; 49():163-4. PubMed ID: 13855182
    [No Abstract]   [Full Text] [Related]  

  • 40. DIOCTYL SODIUM SULFOSUCCINATE TABLET COATING.
    SCHALKER WL; VINCENT MC
    J Pharm Sci; 1964 Jul; 53():818-21. PubMed ID: 14209488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.